关注
Kyle Cuneo
Kyle Cuneo
在 med.umich.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination
J Yu, MD Green, S Li, Y Sun, SN Journey, JE Choi, SM Rizvi, A Qin, ...
Nature medicine 27 (1), 152-164, 2021
5682021
A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer
MJ Whitley, DM Cardona, AL Lazarides, I Spasojevic, JM Ferrer, J Cahill, ...
Science translational medicine 8 (320), 320ra4-320ra4, 2016
2482016
Histone deacetylase (HDAC) inhibitor LBH589 increases duration of γ-H2AX Foci and confines HDAC4 to the cytoplasm in irradiated non–small cell lung cancer
L Geng, KC Cuneo, A Fu, T Tu, PW Atadja, DE Hallahan
Cancer research 66 (23), 11298-11304, 2006
1952006
Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas
KC Cuneo, JJ Vredenburgh, JH Sampson, DA Reardon, A Desjardins, ...
International Journal of Radiation Oncology* Biology* Physics 82 (5), 2018-2024, 2012
1942012
Stereotactic body radiation therapy as an alternative to transarterial chemoembolization for hepatocellular carcinoma
E Sapir, Y Tao, MJ Schipper, L Bazzi, PM Novelli, P Devlin, D Owen, ...
International Journal of Radiation Oncology* Biology* Physics 100 (1), 122-130, 2018
1622018
Dose escalation trial of the Wee1 inhibitor adavosertib (AZD1775) in combination with gemcitabine and radiation for patients with locally advanced pancreatic cancer
KC Cuneo, MA Morgan, V Sahai, MJ Schipper, LA Parsels, JD Parsels, ...
Journal of Clinical Oncology 37 (29), 2643-2650, 2019
1492019
PD-L1 expression in circulating tumor cells increases during radio (chemo) therapy and indicates poor prognosis in non-small cell lung cancer
Y Wang, TH Kim, S Fouladdel, Z Zhang, P Soni, A Qin, L Zhao, E Azizi, ...
Scientific reports 9 (1), 566, 2019
1452019
Concurrent stereotactic radiosurgery and bevacizumab in recurrent malignant gliomas: a prospective trial
AR Cabrera, KC Cuneo, A Desjardins, JH Sampson, F McSherry, ...
International Journal of Radiation Oncology* Biology* Physics 86 (5), 873-879, 2013
1182013
Quantitative proteomic analysis of serum exosomes from patients with locally advanced pancreatic cancer undergoing chemoradiotherapy
M An, I Lohse, Z Tan, J Zhu, J Wu, H Kurapati, MA Morgan, TS Lawrence, ...
Journal of proteome research 16 (4), 1763-1772, 2017
1092017
p53 functions in endothelial cells to prevent radiation-induced myocardial injury in mice
CL Lee, EJ Moding, KC Cuneo, Y Li, JM Sullivan, L Mao, I Washington, ...
Science signaling 5 (234), ra52-ra52, 2012
952012
SU11248 (sunitinib) sensitizes pancreatic cancer to the cytotoxic effects of ionizing radiation
KC Cuneo, L Geng, A Fu, D Orton, DE Hallahan, AB Chakravarthy
International Journal of Radiation Oncology* Biology* Physics 71 (3), 873-879, 2008
952008
High-performance chemical isotope labeling liquid chromatography mass spectrometry for exosome metabolomics
X Luo, M An, KC Cuneo, DM Lubman, L Li
Analytical chemistry 90 (14), 8314-8319, 2018
872018
A pilot study of diffusion-weighted MRI in patients undergoing neoadjuvant chemoradiation for pancreatic cancer
KC Cuneo, TL Chenevert, E Ben-Josef, MU Feng, JK Greenson, ...
Translational Oncology 7 (5), 644-649, 2014
832014
Comparison of stereotactic body radiation therapy and radiofrequency ablation in the treatment of intrahepatic metastases
WC Jackson, Y Tao, M Mendiratta-Lala, L Bazzi, DR Wahl, MJ Schipper, ...
International Journal of Radiation Oncology* Biology* Physics 100 (4), 950-958, 2018
722018
Improved quantitative 90Y bremsstrahlung SPECT/CT reconstruction with Monte Carlo scatter modeling
YK Dewaraja, SY Chun, RN Srinivasa, RK Kaza, KC Cuneo, ...
Medical physics 44 (12), 6364-6376, 2017
692017
A specific antagonist of the p110δ catalytic component of phosphatidylinositol 3′-kinase, IC486068, enhances radiation-induced tumor vascular destruction
L Geng, J Tan, E Himmelfarb, A Schueneman, K Niermann, A Fu, ...
Cancer research 64 (14), 4893-4899, 2004
682004
EGFR targeted therapies and radiation: Optimizing efficacy by appropriate drug scheduling and patient selection
KC Cuneo, MK Nyati, D Ray, TS Lawrence
Pharmacology & therapeutics 154, 67-77, 2015
662015
Intraoperative detection and removal of microscopic residual sarcoma using wide‐field imaging
JK Mito, JM Ferrer, BE Brigman, CL Lee, RD Dodd, WC Eward, ...
Cancer 118 (21), 5320-5330, 2012
642012
Imaging findings within the first 12 months of hepatocellular carcinoma treated with stereotactic body radiation therapy
M Mendiratta-Lala, E Gu, D Owen, KC Cuneo, L Bazzi, TS Lawrence, ...
International Journal of Radiation Oncology* Biology* Physics 102 (4), 1063-1069, 2018
592018
Wee1 kinase inhibitor AZD1775 radiosensitizes hepatocellular carcinoma regardless of TP53 mutational status through induction of replication stress
KC Cuneo, MA Morgan, MA Davis, LA Parcels, J Parcels, D Karnak, ...
International Journal of Radiation Oncology* Biology* Physics 95 (2), 782-790, 2016
592016
系统目前无法执行此操作,请稍后再试。
文章 1–20